Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 468 across all filing types
Latest filing 2025-03-05 Regulatory Filings
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-03-05 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-03-05 English
Board Meeting — Other business matters
Regulatory Filings
2025-03-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter dated February 26, 2025, addressed to stock exchanges, informing them about scheduled meetings between company officials and analysts/institutional investors. It mentions that an Investor Presentation has been uploaded on the stock exchanges and the company's website. The document is short (2616 characters) and serves as a notification of upcoming investor meetings and the availability of the presentation, rather than containing the presentation itself or detailed financial data. It is not a full report, earnings release, or regulatory filing but an announcement related to investor communications. Therefore, the document best fits the category of Investor Presentation (IP) as it relates to investor meetings and presentation materials.
2025-02-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a notification about the schedule of analyst and institutional investor meetings, referencing SEBI Listing Regulations. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges, but the document itself is not the presentation. The document is short (2608 characters) and serves as an announcement of the meeting schedule and the availability of the presentation, not the presentation content itself. Therefore, it fits the category of an Investor Presentation announcement or related update. Given the options, the best fit is 'Investor Presentation' (IP) since it directly references the investor presentation and meeting schedule for investors.
2025-02-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter dated February 26, 2025, addressed to stock exchanges, informing them about a scheduled meeting between company officials and analysts/institutional investors. It references SEBI Listing Regulations and mentions that an investor presentation has been uploaded on the company's website and stock exchanges. The document does not contain financial statements or detailed financial data but is an announcement about upcoming investor meetings and the availability of an investor presentation. The document length is 2617 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as an Investor Presentation (IP) announcement or related notice. Given the content focuses on the schedule and availability of the investor presentation, the most appropriate classification is Investor Presentation (IP).
2025-02-26 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.